PRECIVITYAD2 Trademark
Trademark Overview
On Tuesday, March 21, 2023, a trademark application was filed for PRECIVITYAD2 with the United States Patent and Trademark Office. The USPTO has given the PRECIVITYAD2 trademark a serial number of 97848658. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, November 21, 2024. This trademark is owned by C2N Diagnostics, LLC. The PRECIVITYAD2 trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical diagnostic reagents and assays for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease detection, diagnosing, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases
Medical testing for diagnostic or treatment purposes; medical laboratory, diagnostic testing, monitoring and reporting services; medical testing for disease, illness, and pathology tracking, treating, and prevention purposes
General Information
| Serial Number | 97848658 |
| Word Mark | PRECIVITYAD2 |
| Filing Date | Tuesday, March 21, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 26, 2023 |
Trademark Statements
| Description of Mark | The mark consists of a circle made up of various sized full circles to the left of the PrecivityAD2. |
| Goods and Services | Medical diagnostic reagents and assays for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease detection, diagnosing, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases |
| Pseudo Mark | PRECIVITY AD TWO |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical testing for diagnostic or treatment purposes; medical laboratory, diagnostic testing, monitoring and reporting services; medical testing for disease, illness, and pathology tracking, treating, and prevention purposes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 13, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 13, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | C2N Diagnostics, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | St. Louis, MO 63110 |
| Party Name | C2N Diagnostics, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | St. Louis, MO 63110 |
Trademark Events
| Event Date | Event Description |
| Friday, March 24, 2023 | NEW APPLICATION ENTERED |
| Thursday, April 13, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 14, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 4, 2023 | ASSIGNED TO EXAMINER |
| Friday, May 5, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, May 5, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, May 5, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 21, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 26, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 21, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 21, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, May 21, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 22, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 21, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 21, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 21, 2024 | SOU EXTENSION 2 FILED |
| Thursday, November 21, 2024 | SOU EXTENSION 2 GRANTED |
